ANNEXSupplementary provisions
ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 29, Ethofumesate, the date is replaced by ‘31 July 2017’; (2) in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2017’; (3) in the sixth column, expiration of approval, of row 41, Imazamox, the date is replaced by ‘31 July 2017’; (4) in the sixth column, expiration of approval, of row 42, Oxasulfuron, the date is replaced by ‘31 July 2017’; (5) in the sixth column, expiration of approval, of row 44, Foramsulfuron, the date is replaced by ‘31 July 2017’; (6) in the sixth column, expiration of approval, of row 46, Cyazofamid, the date is replaced by ‘31 July 2017’; (7) in the sixth column, expiration of approval, of row 47, 2,4-DB, the date is replaced by ‘31 October 2017’; (8) in the sixth column, expiration of approval, of row 48, Beta-cyfluthrin, the date is replaced by ‘31 October 2017’; (9) in the sixth column, expiration of approval, of row 50, Iprodione, the date is replaced by ‘31 October 2017’; (10) in the sixth column, expiration of approval, of row 51, Linuron, the date is replaced by ‘31 July 2017’; (11) in the sixth column, expiration of approval, of row 52, Maleic hydrazide, the date is replaced by ‘31 October 2017’; (12) in the sixth column, expiration of approval, of row 53, Pendimethalin, the date is replaced by ‘31 July 2017’; (13) in the sixth column, expiration of approval, of row 59, Trifloxystrobin, the date is replaced by ‘31 July 2017’; (14) in the sixth column, expiration of approval, of row 60, Carfentrazone ethyl, the date is replaced by ‘31 July 2017’; (15) in the sixth column, expiration of approval, of row 61, Mesotrione, the date is replaced by ‘31 July 2017’; (16) in the sixth column, expiration of approval, of row 62, Fenamidone, the date is replaced by ‘31 July 2017’; (17) in the sixth column, expiration of approval, of row 63, Isoxaflutole, the date is replaced by ‘31 July 2017’; (18) in the sixth column, expiration of approval, of row 64, Flurtamone, the date is replaced by ‘31 October 2017’; (19) in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2017’; (20) in the sixth column, expiration of approval, of row 66, Iodosulfuron, the date is replaced by ‘31 October 2017’; (21) in the sixth column, expiration of approval, of row 67, Dimethenamid-P, the date is replaced by ‘31 October 2017’; (22) in the sixth column, expiration of approval, of row 68, Picoxystrobin, the date is replaced by ‘31 October 2017’; (23) in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2017’; (24) in the sixth column, expiration of approval, of row 70, Silthiofam, the date is replaced by ‘31 October 2017’; (25) in the sixth column, expiration of approval, of row 71, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), the date is replaced by ‘31 October 2017’.